An Investigation of the Side Effects, Patient Feedback, and Physiological Changes Associated with Direct-Acting Antiviral Therapy for Hepatitis C

Background: Hepatitis C virus (HCV) infection is one of the major causes of liver cirrhosis and hepatocellular carcinoma globally. The advent of direct-acting antivirals (DAAs) with high cure rates provides an opportunity to reduce the rising HCV disease burden. However, few studies have explored th...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Pin-Sheng, Chang, Te-Sheng, Lu, Sheng-Nan, Su, Hsiang-Jou, Chang, Shu-Zhi, Hsu, Chia-Wen, Chen, Mei-Yen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6950306/
https://www.ncbi.nlm.nih.gov/pubmed/31817863
http://dx.doi.org/10.3390/ijerph16244981

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6950306/
https://www.ncbi.nlm.nih.gov/pubmed/31817863
http://dx.doi.org/10.3390/ijerph16244981

Ejemplares similares